НЕРВНАЯ РЕГУЛЯЦИЯ ФУНКЦИИ ЩИТОВИДНОЙ ЖЕЛЕЗЫ

Обложка


Цитировать

Полный текст

Аннотация

В обзоре рассмотрены вопросы вегетативной регуляции функции щитовидной железы. Активация центральных α-адренергических механизмов увеличивает высвобождение тиреотропного гормона гипофиза преимущественно за счет стимуляции его секреции. Дофамин угнетает секрецию этого гормона, воздействуя на D2-рецепторы тиреотропоцитов. Ацетилхолин и другие холиномиметики угнетают функциональную активность тиреоцитов при участии мускариновых рецепторов. Наряду симпатическим и парасимпатическим отделом особое внимание уделено роли серотонинергического отдела вегеьтативной нервной системы. Серотонин может блокировать секрецию тиреотропина гипофизом, однако оказывает прямое стимулирующее влияние на тиреоциты. Этот стимуляторный эффект серотонина опосредован 5-НТ2-рецепторами. При гипотиреозе угнетен синтез и метаболизм серотонина в мозге. Депрессия сопровождается угнетением активности фермента дейодиназы типа 2, что способствует снижению содержания серотонина при депрессии. Активация 5-НТ1-рецептора приводит к увеличению содержания внутриклеточного кальция, вызывая торможение активности промоутера кальцитонин ген-ассоциированного пептида.

 

Об авторах

А. Э. Лычкова

Центральный научно-исследовательский институт гастроэнтерологии, Москва, Российская Федерация

Автор, ответственный за переписку.
Email: lychkova@mail.ru
PhD, Head of the Clinical Physiology Laboratory, Central Research Institute of Gastroenterology Department of Moscow Public Health Address: 129343, Moscow, Entuziastov highway, 86; tel.: (499) 180-41-12 Россия

Список литературы

  1. Magner J.A. Thyroid-stimulating hormone: biosynthesis, cell biology and bioactivity. Endocr. Rev. 1990; 11 (2): 354–385.
  2. Sapronov N.S., Fedotova Yu.O. Gormony gipotalamo–gipofizarno–tireoidnoi sistemy i mozg [The hormones of the hypothalamic-pituitary-thyroid system and the brain]. St. Petersburg, Lan', 2002. 184 p.
  3. Fedotova Yu.O., Sapronov N.S. Effekty tireoidnykh gormonov v tsentral'noi nervnoi sisteme. Osnovy neiroendokrinologii. Pod red. V.G. Shalyapina, P.D. Shabanova [Effects of thyroid hormones in the central nervous system. In: Fundamentals Neuroendocrinology.V.G. Shalyapin, P.D. Shabanov (edtors)]. St. Petersburg, Elbi-SPb, 2005. p. 204–249.
  4. Klieverik L., Kalsbeek A., Fliers E. Autonomic innervation of the rhyroid gland and its functional implications. Hot Thyroidology. 2005; 1:3-4.
  5. Sundler F., Grunditz T., Hakanson R., Uddman R. Innervation of the thyroid. A study of the rat using retrograde tracing and immunohistochemistry. Acta Histochem. 1989; Suppl. Band XXXVII: 191–198.
  6. Munoz–Cruzado Poce M.J., Garcia Navas A.J., Moreno Gomez M.L. Prevalence of thyroid disorders in patients diagnosed with depression. Aten. Primaria. 2000; 26 (3): 176–179.
  7. Dedov I.I., Balabolkin M.I., Marova E.I. Bolezni organov endokrinnoi sistemy [Diseases of organs of the endocrine system]. Мoscow, Meditsina, 2000. 568 p.
  8. Michalkiewicz M., Dey M., Huffman L., Hedge G.A. The neuropeptides, VIP and NPY, that are present in the thyroid nerves are not released into the thyroid vein. Thyroid. 1998; 8 (11): 1071–1077.
  9. Ahren B., Bengtsson H.I., Hedner P. Effects of norepinephrine on basal and thyrotropin-stimulated thyroid hormone secretion in the mouse. Endocrinology. 1986; 119 (3): 1058–1062.
  10. Young J.B., Burgi-Saville M.E., Burgi U., Landsberg L. Sympathetic nervous system activity in rat thyroid: potential role in goitrogenesis. Am. J. Physiol. Endocrinol. Metab. 2005; 288: 861–867.
  11. Maayan M.L., Volpert E.M., Debons A.F. Neurotransmitter regulation of thyroid activity. Endocr. Res.1987; 13 (2): 199–212.
  12. Rack S.K., Makela E.H. Hypothyroidism and depression: a therapeutic challenge. Ann. Pharmacother. 2000; 34 (10): 1142–1145.
  13. Gur E., Lifschytz T., Lerer B., Newman M.E. Effects of triiodothyronine and imipramine on basal 5-HT levels and 5-HT(1) autoreceptor activity in rat cortex. Eur. J. Pharmacol. 2002; 457 (1): 37–43.
  14. Dey M., Michalkiewicz M., Huffman L.J., Hedge G.A. Thyroidal vascular responsiveness to parasympathetic stimulation is increased in hyperthyroidism. Am. J. Physiol. 1993; 264 (3 Pt. 1): 398–402.
  15. Dey M., Michalkiewicz M., Dey M., Hedge G.A. NPY is not a primary regulator of the acute thyroid blood flow respons to sympathetic nerve stimulation. Am. J. Physiol. 1993; 265: 24–30.
  16. Pietrzyk Z., Michalkiewicz M., Huffman L.J., Hedge G.A. Vasoactive intestinal peptide enhances thyroidal iodide uptake during dietary iodine deficiency. Endocr. Res. 1992; 18 (3): 213–228.
  17. Michalkiewicz M., Huffman L.J., Dey M., Hedge G.A. Immunization against vasoactive intestinal peptide does not affect thyroid hormone secretion or thyroid blood flow. Am. J. Physiol. 1994; 266: 905–913.
  18. Consolo S., Garattini S., Ghielmetti R. Morselli P., Valzelli L. The hydroxylation of tryptophan in vivo by brain. Life Sci. 1965; 4: 625–630.
  19. Reiter R.J. The pineal gland and melatonin in relation to aging: a summary of the theories and of the data. Exp. Gerontol. 1995; 30 (3–4): 199–212.
  20. Vinogradov S.Yu., Pogorelov Yu.V. Neuromediator bioamines of the thyroid gland and structuro-functional aspects of its homeostasis. Arkhiv anatomii, gistologii i embriologii = Archives of Anatomy, Histology and Embryology. 1987; 1: 12–22.
  21. Gershon M.D., Belshaw B.E., Nunez E.A. Biochemical, histochemical and ultrastructural studies of thyroid serotonin, parafollicular and follicular cells during development in the dog. Am. J. Anat. 2005; 132 (1): 5–19.
  22. Brizzi G., Carella C., Foglia M.C., Frigino M. Thyroid hormone plasmatic levels in rats treated with serotonin in acute and chronic way. J. Physiol. Paris. 1997; 91 (6): 307–310.
  23. Broedel O., Eravci M., Fuxius S., Smolarz T., Jeitner A., Grau H., Stoltenburg-Didinger G., Plueckhan H, Meinhold H, Baumgartner A.. Effects of hyper- and hypothyroidism on thyroid hormone concentrations in regions of the rat brain. Am. J. Physiol. Endocrinol. Metab. 2003; 285 (3): 470–480.
  24. Raikhlin N.T., Kvetnoi I.M. Diffuznaya endokrinnaya sistema (APUD-sistema) [Diffuse endocrine system (APUD-system)]. Мoscow, Meditsina, 1992.
  25. Тejani-Butt S.M., Yang J., Kaviani A. Time course of altered thyroid states on 5-НТ1A receptors and 5-НТ uptake sites in rat brain: An autoradiographic analysis. Neuroendocrinology. 1993; 57: 1011–1018.
  26. Heal D.J., Smith S.L. The effects of acute and repeated administration of T3 to mice on 5-НТ1 and 5-НТ2 function in the brain and its influence on the actions of repeated eletroconvulsive shock. Neuropharmacol. 1998; 27: 1239–1248.
  27. Haas M.J., Mreyoud A., Fishman M., Mooradian A.D. Microarray analysis of thyroid hormone-induced changes in mRNA expression in the adult rat brain. Neurosci. Lett. 2004; 365 (1):14–18.
  28. Salvatore D., Low S.C., Berry M. Maia A.L., Harney J.W., Croteau W., St Germain D.L., Larsen P.R. Type 3 iodothyronine deiodinase: cloning, in vitro expression, and functional analysis of the placental selenoenzyme. J. Clin. Invest. 1995; 96: 2421–2430.
  29. Crocker A.D., Overstreet D.H., Crocker J.M. Hypothyroidism leads to increased dopamine receptor sensitivity and concentration. Pharmacol. Biochem. Behav. 1986; 24 (6): 1593–1597.
  30. Larisch R., Kley K., Nikolaus S., Franz M,, Hautzel H., Tress W., Müller H.W. Depression and anxiety in different thyroid function states. Horm. Metab. Res. 2004; 36 (9): 650–653.
  31. Campos-Barros A., Meinhold H., Stula M., Müller F., Köhler R., Eravci M., Putzien O., Baumgartner A. The influence of desipramine on thyroid hormone metabolism in rat brain. J. Pharmacol. Exp. Therapeut. 1994; 268: 1143–1152.
  32. Baumgartner A., Dubeyko M., Campos-Barros A. Eravci M, Meinhold H. Subchronic administration on fluoxetine to rats affects triiodothyronine production and deiodination in regions of the cortex and in the limbic forebrain. Brain Res. 1994; 635: 68–74.
  33. Hein M.D., Jackson I.M.D. Review: Thyroid Function in Psychiatric Illness. Gen. Hosp. Psychiatry. 1990; 12: 232–244.
  34. Kirkegaard C. The thyrotropin response to thyrotropin-releasing hormone in endogenous depression. Psychoneuroendocrinol. 1981; 6: 189–212.
  35. Gnilorybov M. Neuropeptides and neurogenic mechanisms of arthritis. Ukrainskii revmatologicheskii zhurnal = Ukrainian Journal of Rheumatology. 2004; 2: 8–16.
  36. Zabel M., Dietel M., Gebarowska E., Michael R. Effect of follicular cells on calcitonin gene expression in thyroid parafollicular cells in cell culture. Histochem J. 1999; 31 (3): 175–180.
  37. Naot D., Cornish J. The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism. Bone. 2008; 43 (5): 813–818.
  38. Falck B, Owman C. 5-hydroxytryptamine and related amines in endocrine cell systems. Adv. Pharmacol. 1968; 6 (Pt. A): 211–231.
  39. Moskowitz M.A. Neurogenic versus vascular mechanism of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol. Sci. 1992; 13: 307–311.
  40. Durham P., Russo A. Stimulation of the calcitonin gene-related peptide enhancer by mitogen-activated protein kinases and repression by an antimigraine drug in trigeminal ganglia neurons. J .Neurosci. 2003; 23 (3): 807–815.
  41. Russo A.F., Clark M.S., Durham P.L. Thyroid parafollicular cells. An accessible model for the study of serotonergic neurons. Mol. Neurobiol. 1996; 13 (3): 257–276.
  42. Yoshimura M., Furue H., Ito A. Anti-nociceptive effect of calcitonin on chronic pain associated with osteoporosis. Clin. Calcium. 2001; 11 (9): 1153–1157.
  43. Lychkova A.E., Petrakov A.V., Khomeriki S.G. Modeling osteoporosis. Vestnik Rossiiskoi akademii meditsinskikh nauk = Annals of the Russian Academy of Medical Sciences. 2010; 4: 31–33.
  44. Tamir H., Hsiung S.C., Yu P.Y., Liu K.P., Adlersberg M., Nunez E.A., Gershon M.D. Serotonergic signalling between thyroid cells: protein kinase C and 5-HT2 receptors in the secretion and action of serotonin. Synapse. 1992; 12 (2): 155–168.
  45. Lychkova A.E. Serotonergic nervous system: gradients of neural influences in normal and pathological. Eksperimental'naya i klinicheskaya gastroenterologiya = Experimental and Clinical Gastroenterology. 2003; 6: 114–120.
  46. Lychkova A.E. Mechanisms of synergic action of vegetative nervous system compartments. Uspekhi fiziologicheskikh nauk zhurnal = Success of Physiological Sciences. 2006; 37 (1): 50–67.

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML

© Издательство "Педиатръ", 1970



Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах